Total Payments
$7,209
2024 Payments
$133.81
Companies
12
Transactions
41
Medicare Patients
2,827
Medicare Billing
$317,819
Payment Breakdown by Category
Other$6,450 (89.5%)
Food & Beverage$659.15 (9.1%)
Travel$100.28 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,450 | 9 | 89.5% |
| Food and Beverage | $659.15 | 30 | 9.1% |
| Travel and Lodging | $100.28 | 2 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $6,830 | 26 | $0 (2019) |
| Novocure Inc. | $133.81 | 1 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $55.57 | 2 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $37.80 | 2 | $0 (2017) |
| Takeda Pharmaceuticals America, Inc. | $35.71 | 3 | $0 (2017) |
| AbbVie, Inc. | $22.91 | 1 | $0 (2017) |
| Shire North American Group Inc | $18.84 | 1 | $0 (2017) |
| Ferring Pharmaceuticals Inc. | $18.79 | 1 | $0 (2017) |
| Chiesi USA, Inc. | $15.64 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $15.50 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $133.81 | 1 | Novocure Inc. ($133.81) |
| 2022 | $15.64 | 1 | Chiesi USA, Inc. ($15.64) |
| 2019 | $600.00 | 3 | Allergan Inc. ($600.00) |
| 2018 | $4,144 | 9 | Allergan Inc. ($4,144) |
| 2017 | $2,316 | 27 | Allergan Inc. ($2,086) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $133.81 | General |
| Category: Oncology | ||||||
| 06/16/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $15.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/02/2019 | Allergan Inc. | LINZESS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $200.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/30/2019 | Allergan Inc. | ZENPEP (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $200.00 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 03/14/2019 | Allergan Inc. | LINZESS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $200.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/16/2018 | Allergan Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/08/2018 | Allergan Inc. | VIBERZI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $200.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/08/2018 | Allergan Inc. | VIBERZI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $200.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/02/2018 | Allergan Inc. | LINZESS (Drug), VIBERZI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/02/2018 | Allergan Inc. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $57.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/07/2018 | Allergan Inc. | LINZESS (Drug), VIBERZI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/07/2018 | Allergan Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $80.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/07/2018 | Allergan Inc. | LINZESS (Drug), VIBERZI | Travel and Lodging | In-kind items and services | $50.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/07/2018 | Allergan Inc. | LINZESS (Drug), VIBERZI | Travel and Lodging | In-kind items and services | $50.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/08/2017 | Allergan Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/12/2017 | Allergan Inc. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/19/2017 | Allergan Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $4.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/18/2017 | Allergan Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $3.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/15/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $30.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/08/2017 | Allergan Inc. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $4.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/05/2017 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/26/2017 | Allergan Inc. | LINZESS (Drug), VIBERZI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/26/2017 | Allergan Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $67.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/21/2017 | Allergan Inc. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/14/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $14.08 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 542 | 576 | $412,316 | $65,912 |
| 2022 | 17 | 691 | 756 | $508,232 | $81,812 |
| 2021 | 16 | 853 | 968 | $561,886 | $93,470 |
| 2020 | 14 | 741 | 850 | $427,866 | $76,625 |
Total Patients
2,827
Total Services
3,150
Medicare Billing
$317,819
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 59 | 59 | $69,251 | $13,285 | 19.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 54 | 54 | $54,200 | $10,507 | 19.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 64 | 64 | $69,590 | $8,857 | 12.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 67 | 69 | $27,750 | $7,486 | 27.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 44 | 44 | $49,400 | $6,334 | 12.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 85 | $18,235 | $5,484 | 30.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 60 | 60 | $65,528 | $5,348 | 8.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 45 | 61 | $12,200 | $4,086 | 33.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $22,508 | $1,931 | 8.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $7,024 | $1,745 | 24.8% |
| 43450 | Dilation of esophagus | Facility | 2023 | 18 | 18 | $15,830 | $753.20 | 4.8% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 20 | 20 | $800.00 | $94.88 | 11.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 61 | 61 | $73,060 | $13,150 | 18.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 90 | 90 | $102,900 | $12,471 | 12.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 84 | 89 | $31,150 | $10,133 | 32.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 45 | 45 | $45,000 | $8,877 | 19.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 74 | 76 | $87,747 | $7,093 | 8.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 66 | 100 | $20,000 | $6,093 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 75 | 92 | $18,730 | $6,070 | 32.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 44 | 44 | $49,600 | $5,455 | 11.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 17 | 18 | $18,000 | $3,397 | 18.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 23 | 23 | $22,672 | $2,138 | 9.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $7,515 | $2,018 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 19 | $5,788 | $1,872 | 32.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 13 | 19 | $3,800 | $1,386 | 36.5% |
About Dr. Brian Gill, M.D
Dr. Brian Gill, M.D is a Gastroenterology healthcare provider based in Plymouth, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2008. The National Provider Identifier (NPI) number assigned to this provider is 1639336423.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Gill, M.D has received a total of $7,209 in payments from pharmaceutical and medical device companies, with $133.81 received in 2024. These payments were reported across 41 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($6,450).
As a Medicare-enrolled provider, Gill has provided services to 2,827 Medicare beneficiaries, totaling 3,150 services with total Medicare billing of $317,819. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Plymouth, MA
- Active Since 05/20/2008
- Last Updated 03/23/2017
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639336423
Products in Payments
- LINZESS (Drug) $6,062
- VIBERZI (Drug) $568.30
- ZENPEP (Drug) $200.00
- Optune (Device) $133.81
- XIFAXAN (Drug) $55.57
- ZEPATIER (Drug) $37.80
- Amitiza (Drug) $35.71
- Humira (Biological) $22.91
- GATTEX (Drug) $18.84
- PREPOPIK (Drug) $18.79
- CLEVIPREX (Drug) $15.64
- STELARA (Biological) $15.50
- Alinia Tablets 500mg 30 count bottle (Drug) $10.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Plymouth
Dr. Daniel Van Handel, M.d, M.D
Gastroenterology — Payments: $69,506
Gastroenterology $69,506
Jose Vega Peralta, M.d, M.D
Gastroenterology — Payments: $6,849
Gastroenterology $6,849
Mitchell Oliver, M.d, M.D
Gastroenterology — Payments: $2,306
Gastroenterology $2,306
Soroya Rahaman, Md, MD
Gastroenterology — Payments: $2,225
Gastroenterology $2,225
Maysaa El Zoghbi, M.d, M.D
Gastroenterology — Payments: $1,149
Gastroenterology $1,149
Jonathan Russo, Md, MD
Gastroenterology — Payments: $711.21
Gastroenterology $711.21